VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $305,500 | +281.9% | 32,500 | +11.1% | 0.02% | +325.0% |
| Q3 2022 | $80,000 | -5.9% | 29,258 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $85,000 | -41.8% | 29,258 | -39.6% | 0.00% | -40.0% |
| Q1 2022 | $146,000 | +64.0% | 48,458 | +151.6% | 0.01% | +66.7% |
| Q4 2021 | $89,000 | -26.4% | 19,258 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $121,000 | +5.2% | 19,258 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $115,000 | -5.7% | 19,258 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $122,000 | -75.2% | 19,258 | -78.0% | 0.01% | -75.0% |
| Q4 2020 | $492,000 | -3.3% | 87,400 | 0.0% | 0.02% | -16.7% |
| Q3 2020 | $509,000 | -20.0% | 87,400 | -0.9% | 0.02% | -31.4% |
| Q2 2020 | $636,000 | +26.9% | 88,200 | -17.7% | 0.04% | -10.3% |
| Q1 2020 | $501,000 | +381.7% | 107,200 | +724.6% | 0.04% | +680.0% |
| Q4 2019 | $104,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |